Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Why aren’t doctors using digital therapeutics?

    White Papers and Resources | December 4, 2019 | Blue Latitude Health

    The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...

    Four Health wins Judges Special Recognition Award PMEA 2019

    Press Releases | November 29, 2019 | Four Agency Worldwide

    We’re delighted to have won the Judge’s Special Recognition Award at the PMEA Awards 2019! Huge congratulations to the whole team for another amazing win for the GLAD I Took...

    Lucid Group announces the appointment of a new Legal and Compliance manager

    Press Releases | November 27, 2019 | Lucid Group Communications Limited

    Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...

    Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

    Press Releases | November 27, 2019 | Lucid Group Communications Limited

    This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

    Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

    White Papers and Resources | November 27, 2019 | OPEN Health

    A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

    Bedrock’s on fire for Wellbeing Week

    Press Releases | November 26, 2019 | Bedrock Healthcare Communications

    Bedrock creates a positive working environment to enable individuals and our business to thrive.

    WHITE PAPER: Patient nonadherence – the $637bn paradox

    White Papers and Resources | November 25, 2019 | IGNIFI

    What’s not changed for 50 years, kills 200,000 Europeans annually, costs pharma $637 billion and the NHS over £500 million a year? We’ll tell you.

    Spotlight interview: 15 minutes on insights and market research in pharma

    White Papers and Resources | November 21, 2019 | OPEN Health

    Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

    Early diagnosis underpins NHS cancer strategy

    White Papers and Resources | November 20, 2019 | Wilmington Healthcare

    Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan

    Launch Excellence 2020

    White Papers and Resources | November 20, 2019 | Blue Latitude Health

    In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch...